Free Trial

Pheton (PTHL) Competitors

Pheton logo
$29.15 +0.73 (+2.57%)
Closing price 04:00 PM Eastern
Extended Trading
$29.17 +0.02 (+0.07%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PTHL vs. EMBC, SMLR, CBLL, KIDS, AVNS, BVS, AXGN, BFLY, DCTH, and TMCI

Should you be buying Pheton stock or one of its competitors? The main competitors of Pheton include Embecta (EMBC), Semler Scientific (SMLR), CeriBell (CBLL), OrthoPediatrics (KIDS), AVANOS MEDICAL (AVNS), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), Delcath Systems (DCTH), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.

Pheton vs. Its Competitors

Embecta (NASDAQ:EMBC) and Pheton (NASDAQ:PTHL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Embecta currently has a consensus price target of $19.00, indicating a potential upside of 61.98%. Given Embecta's stronger consensus rating and higher possible upside, research analysts clearly believe Embecta is more favorable than Pheton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Embecta
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Pheton
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Embecta had 2 more articles in the media than Pheton. MarketBeat recorded 4 mentions for Embecta and 2 mentions for Pheton. Pheton's average media sentiment score of 1.31 beat Embecta's score of 0.72 indicating that Pheton is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Embecta
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Pheton
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.8% of Embecta shares are owned by institutional investors. 0.4% of Embecta shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Embecta has higher revenue and earnings than Pheton.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Embecta$1.12B0.61$78.30M$0.9013.03
Pheton$450K426.24-$660KN/AN/A

Embecta has a net margin of 4.89% compared to Pheton's net margin of 0.00%. Pheton's return on equity of 0.00% beat Embecta's return on equity.

Company Net Margins Return on Equity Return on Assets
Embecta4.89% -19.67% 12.27%
Pheton N/A N/A N/A

Summary

Embecta beats Pheton on 10 of the 13 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTHL vs. The Competition

MetricPhetonMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$187.06M$7.30B$5.70B$9.51B
Dividend YieldN/A2.84%4.69%4.01%
P/E RatioN/A25.2828.0720.05
Price / Sales426.2442.17448.5799.42
Price / CashN/A26.7436.2258.56
Price / Book31.019.718.665.87
Net Income-$660K$239.96M$3.25B$258.55M
7 Day Performance31.19%2.92%4.20%2.23%
1 Month Performance70.27%6.14%10.82%12.76%
1 Year PerformanceN/A17.27%34.70%19.36%

Pheton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTHL
Pheton
N/A$29.15
+2.6%
N/AN/A$187.06M$450K0.0011Positive News
Gap Up
EMBC
Embecta
4.6895 of 5 stars
$10.29
+5.2%
$19.00
+84.6%
-30.4%$571.57M$1.12B11.432,100
SMLR
Semler Scientific
3.3002 of 5 stars
$39.67
-3.8%
$89.00
+124.4%
+18.1%$568.63M$56.29M-15.20120
CBLL
CeriBell
2.3197 of 5 stars
$15.21
-2.4%
$32.14
+111.3%
N/A$563.11M$65.44M0.00N/A
KIDS
OrthoPediatrics
4.1953 of 5 stars
$21.88
-0.6%
$35.83
+63.8%
-32.8%$534.56M$212.45M-12.50200
AVNS
AVANOS MEDICAL
2.9339 of 5 stars
$11.40
+1.6%
N/A-47.3%$518.86M$687.80M-1.362,227News Coverage
Upcoming Earnings
BVS
Bioventus
3.3644 of 5 stars
$6.30
+0.6%
$13.75
+118.3%
-14.2%$517.51M$567.70M-10.331,200
AXGN
AxoGen
2.2101 of 5 stars
$11.61
+2.9%
$24.50
+111.0%
+42.5%$513.74M$194.52M-77.39450
BFLY
Butterfly Network
2.471 of 5 stars
$1.89
+0.8%
$3.50
+85.7%
+93.1%$462.43M$82.06M-6.50460News Coverage
Upcoming Earnings
DCTH
Delcath Systems
2.7562 of 5 stars
$11.32
+0.6%
$24.00
+112.0%
+29.0%$391.80M$37.21M-22.6460News Coverage
TMCI
Treace Medical Concepts
2.8538 of 5 stars
$5.72
+1.2%
$10.52
+83.9%
-26.6%$355.33M$209.36M-6.73250Positive News

Related Companies and Tools


This page (NASDAQ:PTHL) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners